A new study presented at UEG Week 2022 revealed that the Mediterranean diet, rich in fiber, mono-unsaturated fatty acids, and polyphenols, improved immunotherapy response rates and progression-free survival in advanced melanoma patients.

The study was presented by researchers from the University Medical Center Groningen, Netherlands. According to the study, diet plays an important role in the success of immunotherapy, and trials are being expanded to investigate outcomes for different tumor types, including digestive cancers. In the study, the dietary intake of 91 patients with advanced melanoma was recorded by the researchers. These participants were simultaneously treated with ICI drugs, while, on the other hand, their progress was monitored with regular radiographic response check-ups.

The findings of the study showed a significant association between the overall response rate and the Mediterranean diet. Also, the Mediterranean diet was significantly associated with progression-free survival at 12 months. The study also revealed that consuming whole grains and legumes reduced the likelihood of developing drug-induced immune-related side effects, such as colitis.

In contrast, red and processed meat increased the probability of developing immune-related side effects.

(Source: https://www.daijiworld.com/news/newsDisplay?newsID=1008113 )